Mer­ck’s $10.8B Prometheus buy­out, GSK’s $2B Bel­lus takeover fu­el M&A buzz; CAR-T da­ta leak; Best of #AACR23; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’re get­ting ready to dive in­to Q1 earn­ings next week from some of the biggest phar­ma play­ers. There are al­so sev­er­al key FDA de­ci­sions on our watch list. Stay tuned for the most up-to-date cov­er­age.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.